Munekazu Iinuma

Title: Innovations and Contributions of Munekazu Iinuma

Introduction

Munekazu Iinuma is a notable inventor based in Gifu, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of 11 patents. His work focuses on developing drugs that enhance PPAR agonist activities, which are crucial for treating lifestyle diseases.

Latest Patents

One of his latest patents is a lifestyle disease improving drug that enhances PPARα, δ, and γ agonist activities. This drug includes a compound with a lactone structure, specifically a 6-alkyl-5,6-dihydro-2H-pyran-2-one, where the alkyl group contains 4, 5, or 6 carbons. The methods disclosed in this patent involve providing a composition of the active ingredient in a biologically acceptable medium and administering an effective amount to a vertebrate for medical treatment. Another significant patent is related to a novel trans-2-decenoic acid derivative, which is useful as a pharmaceutical agent for various conditions, including peripheral nerve disorders and neurodegenerative diseases. This compound is represented by a general formula where X can be a substituent such as a 1-pyrrolidyl or a piperidino.

Career Highlights

Munekazu Iinuma has worked with esteemed organizations such as the Nagoya Industrial Science Research Institute and Nippon Zoki Pharmaceutical Co., Ltd. His experience in these institutions has contributed to his expertise in pharmaceutical innovations.

Collaborations

He has collaborated with notable coworkers, including Shoei Furukawa and Mitsuru Naiki, which has further enriched his research and development efforts.

Conclusion

Munekazu Iinuma's contributions to pharmaceutical innovations through his patents and collaborations highlight his significant role in advancing medical treatments. His work continues to impact the field positively.